Search

Author/Creator Barriere, David A.

1. Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3. Issue 10 (27th October 2022)

Authors:
Jacquot, Florian; Khoury, Spiro; Labrum, Bonnie; Delanoe, Kévin; Pidoux, Ludivine; Barbier, Julie; Delay, Lauriane; Bayle, Agathe; Aissouni, Youssef; Barriere, David A.; Kultima, Kim; Freyhult, Eva; Hugo, Anders; Kosek, Eva; Ahmed, Aisha S.; Jurczak, Alexandra; Lingueglia, Eric; Svensson, Camilla...
Journal:
Pain
Issue:
Volume 163:Issue 10(2022)
Page Start:
1999
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. (15th September 2018)

Authors:
Poupon, Laura; Lamoine, Sylvain; Pereira, Vanessa; Barriere, David A.; Lolignier, Stéphane; Giraudet, Fabrice; Aissouni, Youssef; Meleine, Mathieu; Prival, Laëtitia; Richard, Damien; Kerckhove, Nicolas; Authier, Nicolas; Balayssac, David; Eschalier, Alain; Lazdunski, Michel; Busserolles, Jérôme
Journal:
Neuropharmacology
Issue:
Volume 140(2018)
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search